Myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: Patients with myocardial infarction receiving ß-caryophyllene 150 mg once daily for one month along with standard treatment. Intervention 2: Control group: Patients
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with myocardial infarction according to the American College of Heart criteria Consent to admission to the study Age more than 18 years old Both male and female gender No kidney failure under hemodialysis No kidney failure and GFR less than 30 No severe liver failure with liver enzymes three times more than normal Not pregnant No previous treatment with ß-caryophyllene
Exclusion criteria
Exclusion criteria: Lack of consent to continue the study History of allergy to ß-caryophyllene
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in hs-CRP serum level. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in CBC diff. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit.;Changes in lipid profile. Timepoint: At the beginning of the study and after 4 weeks of treatment. Method of measurement: Laboratory kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Vafa Baradaran Rahimi
Mashhad University of Medical Sciences
Outcome results
None listed